Cynata Therapeutics Limited (ASX:CYP)
Australia · Delayed Price · Currency is AUD 0.0110
-0.0010 (-8.33%)
Oct 30, 2026, 9:59 AM AEDT
Cynata Therapeutics Market Cap
Cynata Therapeutics has a market cap or net worth of 2.68 million as of October 29, 2026. It is the 47,884th most valuable company in the world and the 1,635th biggest in Australia. Its market cap has decreased by 95.97% in one year.
Market Cap
2.68M
Enterprise Value
1.78M
Revenue
1.71M
Global Rank
Country Rank
#1,635 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2007, Cynata Therapeutics's market cap has decreased from 15.60M to 2.68M, a decrease of -82.83%. That is a compound annual growth rate of -8.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 2.92M | -96.43% |
| Dec 31, 2025 | 81.92M | 51.54% |
| Dec 31, 2024 | 54.06M | 140.76% |
| Dec 29, 2023 | 22.45M | -47.76% |
| Dec 30, 2022 | 42.98M | -44.95% |
| Dec 31, 2021 | 78.09M | -17.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cambium Bio | 12.36M |
| AdAlta | 9.64M |
| Invex Therapeutics | 7.52M |
| Zelira Therapeutics | 5.95M |
| Acrux | 5.90M |
| Tissue Repair | 5.74M |
| Bio-Gene Technology | 5.69M |
| Biotron | 5.57M |